Monthly Archives: May 2018

Everything to be gained by breastfeeding, nothing to lose

In Natural Immunity and VaccinationTetyana Obukhanych, Ph.D states that the measles vaccine has probably eradicated much of the wild measles infection. Then she asks: But is this a good thing?

Answering her own question with a firm ‘no’ she explains that in eradicating the wild measles infection we are also putting an end to something else, something precious and this is maternal immunity. Dr Tetyana adds that we are actually eliminating this amazing maternal immunity even faster than the measles virus.

Natural immunity

In past generations most of us had childhood infections such as measles, mumps, rubella and chicken pox. We encountered these viruses during our childhood and had acquired natural and lifelong immunity before child-bearing age. This is vital for during pregnancy mothers can pass on this immunity via the placenta and through breastfeeding. Such immunity lasts 6 months after the birth of the infant continuing and extended by length of breastfeeding. Because of this amazing maternal immunity now being eliminated through the mass use of vaccines, it was very rare for an infant to develop measles infection.

In 1990s there was a measles outbreak in USA where it was observed that some young infants developed measles and some didn’t. The infants who didn’t get measles were the babies of mothers who were born before 1963 (date when measles vaccine was introduced in the U.S) and the infants who developed measles were born to younger mothers who were more likely to have been vaccinated. The reason that the babies didn’t develop measles during the outbreak would be due to maternal immunity which was not available to the babies born to younger and vaccinated mothers.

Sadly in the same way as we are eliminating maternal immunity to measles we are on the way to eradicating maternal protection from common childhood infections such as mumps, rubella and chicken pox. (The vaccines for these being introduced at later dates). This is tragic for when there are outbreaks of mumps, rubella and chicken pox, young infants who in earlier times would have been covered by their mother’s immunity, will most likely be infected for young girls all over the world are now vaccinated.

‘Mass vaccination’, says Dr Tetyana, is resulting in a leaky herd immunity and this is because many of the vaccinated are called ‘low responders’ to the vaccine. We have ruined this natural immunity which was reinforced among adults when their offspring developed the childhood infections. How silly are we?

Tetyana Obukhanych discusses the choices available to us in relation to infectious disease control.

Public health model

This model promotes vaccines as the way to control infectious diseases. A better way is the adoption of the personal health model.

Personal Health Model

In this way we choose to leave the virus alone and keep our babies well so if they are infected it will be a very mild case of disease. This involves breastfeeding the infant and  attention given to ensuring a nutritious diet. It also involves avoiding fever suppressing medicine such as paracetamol.

Screen Shot 2018-05-23 at 11.09.05 AM

The immune system gradually matures during infancy. Critical early protection against many infectious diseases previously experienced by the mother is given by the passive IgG antibody transferred from the mother via the placenta and in milk.

The infant immune system is transitioning to deal with life. Breastfeeding provides this protection by way of a ‘surrogate immune system‘ that includes the secretion of proteins that exist in breast milk and have antibacterial functions such as secreted IgA and other protective substances such as oligosaccharides that bind with bad bacteria and eliminate them avoiding gut inflammation.

The gut flora is vital in keeping the infant well. Lactobacteria in the gut is promoted by breastfeeding – the presence of this bacteria regulates the junctions in the gut preventing leaky gut. Breastfeeding has been shown to be protective against diarrhoea and also common ear infections and meningitis.  It also has a role in the prevention of chronic diseases.

Everything to be gained by breastfeeding, nothing to lose

As the child grows, attention must be given to nutrition and the importance of vitamins such as A and D. When infection strikes, macrophages pick up the virus and replicate it.  They then secrete interferon which sends signals to cells to fight the infection. However the function of interferon depends on adequate levels of vitamin A. In countries such as Africa where diets are deficient in vitamin A, measles is deadly, so supplementation of children with vitamin A is given.

Vitamin D is also vital for good health in that it activates some of the cells of the immune system and causes the secretion of substances such as antimicrobial peptides which helps with fighting infections. It is especially effective in fighting influenza. This explains why flu is more virulent in the winter when our vitamin D levels are low. Dietary supplementation with foods high in vitamin D is essential for immunity. Cod liver oil has sustained populations for many generations. See: Weston A. Price Foundation for more information about Vitamin D rich foods.

We have wonderful bodies which are designed to heal. There is no need for vaccines. We can build our immune systems and make ourselves and our children strong.

 

Advertisements

Leave a comment

Filed under books, health, Media and health, media representation, politics, vaccination, vaccines

Whooping cough vaccines for expectant mothers?

What are pregnant women to do?

Screen Shot 2018-05-23 at 11.09.05 AMAmong the advice given to expectant mothers is to avoid alcohol, limit fish intake, and choose wisely when consuming cheese. So I am both astonished and saddened that young mothers-to-be are now advised to be vaccinated.

The Australian Government recently announced it will provide the whooping-cough (pertussis) vaccine free to every pregnant woman in the country. The measure was included in the 2018 budget at a cost of $39.5 million ensuring that the vaccine becomes part of Australian National Immunisation Program.

The DTPa vaccine is used to provide protection against three diseases, diphtheria, tetanus, and pertussis (whooping-cough) and is given to children at 2, 4 and 6 months followed by another dose at 18 months and yet another at 4 years. At 10-15 years another dose is given as part of the school vaccination program. Now it is recommended for all pregnant women, ideally at 28 weeks, during their third trimester.

What Is Pertussis?

Pertussis or whooping-cough, is a respiratory disease caused by the Bordetella (B) pertussis bacterium.

Australia is currently experiencing extremely high levels of reported whooping-cough. This situation has continued for a decade and has, at times, seen the reported rate of whooping cough reach levels similar to those recorded prior to mass vaccination in 1953, and has culminated in nearly 40,000 cases reported in 2011. Ironically, this increased level of reported illness has occurred during the same period that vaccination for the disease has increased substantially.

History Of Pertussis

Decline of pertussis

In 1922, there were 107,473 pertussis cases reported in the U.S. with 5,099 deaths. Mortality associated with pertussis declined dramatically in the 1940s as living conditions improved, including sanitation and hygiene and access to health care.

History Of The Disease In Australia

From the above graph it can be seen that by the time mass vaccination commenced in 1953 with the licensing of the first DTP vaccine, deaths from this disease had already declined by roughly 95%

Problems With The Pertussis Vaccine

1. Pertussis vaccines are not very effective. After an outbreak of whooping cough in highly vaccinated kindergarten children living in Elk Grove, California, concerned health officials suggested that the vaccine was only protective for three years at most.

2. The mass pertussis vaccination program may be causing more dangerous strains of pertussis to emerge resulting in more serious symptoms. There have been reports from around the world that there is a new more virulent strain which differs from that contained in the vaccine. Eighty-four percent of all reported pertussis cases in Australia are reportedly associated with the newer strain.

3. Animal studies have shown that although vaccinated baby baboons didn’t develop symptoms of pertussis when coming into contact with the pertussis bacteria, they still colonized B. pertussis in their throats and so could pass the infection onto others. The study’s lead author, Tod Merkel, explained that when someone is exposed to B. pertussis after recently getting vaccinated, they could be an asymptomatic carrier and infect others. “When you’re newly vaccinated, you are an asymptomatic carrier, which is good for you, but not for the population.”

4. According to Vaccine Adverse Events Reporting System (VAERS) there have been 19,357 serious adverse events as of December 30, 2015 in connection with pertussis-containing vaccines since 1990 and most of these in children three years old and under. The deaths resulting from these adverse events of the vaccine amounted to 2,512, with 90% of deaths in children under three years old.

Pertussis Vaccine Ingredients

Australia uses GlaxoSmithKline’s Boostrix vaccine for adults. The contents of this vaccine are:

diphtheria toxoid, tetanus toxoid and acellular pertussis vaccine dTpa components adsorbed on 0.5mg aluminium and suspended in isotonic sodium chloride. It also contains formaldehyde, polysorbate 80 and glycine in residual amounts

Every dose of the DTPa (diphtheria, tetanus and pertussis) vaccine contains 500 micrograms of aluminium. Aluminium is a neurotoxin and this is injected into the bodies of very young children whose developing brains are extremely vulnerable. Five doses by the age of 5 results in a large amount of the heavy metal accumulating in these growing bodies especially when coupled with the aluminium received by way of other vaccines such as hepatitis B given from birth and again in childhood. This is all very serious and gets even more alarming as the pregnant women are also being coerced into having these aluminium containing vaccines.

Paediatrician Dr. Paul Thomas gives his advice to expectant mothers:

“The problem is that it is a humongous dose of  aluminium you are injecting right into the pregnant mum. It is going to go right into the bloodstream where it has a half-life of over a week during which time it bathes that developing baby’s brain with a known neurotoxin. It’s insanity! I would absolutely under no circumstances do that to my unborn child.”

Screen Shot 2018-05-19 at 8.57.32 AMIt is no surprise then that we are now hearing of an increase in fetal deaths in pregnant women who have been vaccinated against pertussis.

“I received the TDAP, against my instincts, March 17, 2015. My daughter was stillborn April 11, 2015 at 35 6/7 weeks. It is likely she was dead a few days before I found out on April 10, 2015. There was no known cause of death, and no flags or warning signs. We were a low risk pregnancy, with no abnormal prenatal clinical or lab findings”. – Chelsea Nichole Smith

Marcella Piper-Terry in her video Fetal Death Flu Shot & TDAP in Pregnancy discusses foetal demise (death in womb) from vaccines given in pregnancy. A whistleblower from an insurance billing company contacted her with documentation about what is happening in regard to these shots in pregnancy.

Stephanie was given the diphtheria, tetanus, and pertussis vaccine on October 20, 2015 and on November 9, 2015, her baby died at 37  weeks gestation.

Sarah received her flu shot on October 15,  2015 and five days later her baby died. The death was recorded as intrauterine foetal demise.

Melissa received Boostrix which contains 500 micrograms of aluminium on January 8, 2015. On February 13, it was noted that there was a uterine size discrepancy – the baby was not growing normally. On March 30 the baby died.

Ally received TDAP on December 7,  2015 and on the very same day her 29 week foetus had a heart attack and died.

There are many more of these deaths and as Marcella Piper-Terry states, these are not coincidences. She blames the aluminium for these deaths.

We should not be giving pregnant women vaccines. It does not make any sense.

But the fear of one’s baby dying from a case of whooping-cough rages in Australia. But what are the chances of death from the disease?

In Australia in the years from 2006 to 2012 there were 10 deaths in babies under 6 months old2 deaths in 2014 and one in 2015.  Babies under six months of age are most vulnerable to whooping-cough so the importance of  breastfeeding in helping baby develop a stronger immune system in order to resist disease needs to be stressed.

We are mad to risk the health of expectant mothers and their babies by vaccination during pregnancy. Sure the disease is nasty but medical help and hospitalization is available to handle any respiratory distress. As parents and grandparents, we must realize that we cannot control nature. Best we can do is to work with it and not against it.

Please note:

TDAP used for adolescents and adults in the US
DTaP is for children under 7 in US
DPTa is vaccine used for children in Australia
Boostrix or dTpa  is used for adults

Leave a comment

Filed under books, health, history, Media and health, politics, vaccination, vaccines

One vial is not necessarily the same as the next

Screen Shot 2018-05-13 at 6.20.44 PM

Aluminium has been described by immunologist C.A. Janeway as, “immunology’s dirty little secret.”

There are three forms of aluminium which are used as adjuvants in vaccines in order to bring about an immune response:

  • aluminium phosphate
  • aluminium hydroxide
  • amorphous aluminium hydroxyphosphate sulphate

Each shot of Merck’s HPV vaccine, Gardasil, contains 225 micrograms of amorphous aluminium hydroxyphosphate sulphate and Gardasil 9 contains 500 mcgs of the same adjuvant.

Of all the vaccines in 2017, parents report Gardasil to be the most reactive vaccine in adolescents. The stories we hear and the cases I’ve seen are horrendous.
—Dr. Suzanne Humphries

The three types of aluminium work differently in the body. They are not the same –  they are not just interchangeable. These 3 types of aluminium adjuvants differ in how they affect the immune system and so it is vital that we know which adjuvant has been used in a particular vaccine. And yet, it is assumed that what is listed on the package insert on any vaccine is what is in the vial.

We expect that each vaccine is labelled clearly and states what type of aluminium has been used as the adjuvant. But sadly this is not the case. Standardization of aluminium is a problem because particle sizes vary and this presents consistency problems.

In Merck’s Dirty Little SecretDr. Suzanne Humphries wonders why Gardasil hits the immune systems of some of these teenagers so ‘viciously,

“By Merck’s own admission for every 100,000 people who use Gardasil or Gardasil 9 you expect a minimum of 2300 serious adverse events to combat 12 potential cases of cervical cancer.”

A vial of Gardasil contains AAHS or amorphous aluminium hydroxyphospate sulphate chosen because it ‘binds better to the protein antigen and promotes a bigger immune system bonfire with more antibodies.’

Dr. Humphries states that although she always knew that no child can be standardized, she used to believe that vaccines could be, and claims that we cannot be sure that what is printed on the vaccine label matches what is actually in the vaccine.

Dr. Humphries explains the research done by Shirodkar in 1990 in which the whole-cell DPT vaccine label manufactured by Connaught Laboratories listed the adjuvant as ‘aluminium potassium sulphate’ but was really ‘amorphous aluminium hydroxyphosphate sulphate’ or AAHS, the same adjuvant used in Gardasil.

The diptheria and tetanus toxoids that make up the highly problematic whole cell diptheria, pertussis and tetanus vaccines contain the same adjuvant AAHS as is used today in Gardasil.

Could it be that the aluminium might have played a role in the reactions said to be because of the pertussis endotoxin in the whole cell DPT vaccines? Interestingly, there were many reactions in children who were given just the diptheria and tetanus toxoid vaccines. These vaccines did not contain the pertussis endotoxin.

More Dirty Secrets

A New Zealand hepatitis B package insert from 1987 states that the adjuvant used was aluminium hydroxide. However the labelling was wrong and had to be changed to amorphous aluminium hydroxyphosphate meaning that the hepatitis B vaccines were mislabeled for more than a decade and in reality, contained a more reactive adjuvant and one that was difficult to standardize.

Another example was the mislabelling of New Zealand’s VAQTA or the Hepatitis A vaccine.  The 1994 package stated that it contained aluminium hydroxide. However this was incorrect with Merck requesting the label be changed to reflect that the vaccine contained amorphous aluminium hydroxyphospate sulphate or AAHS.  And remember these adjuvants react differently in the body so it is vital that labels are  correct.

We now know that Merck’s vaccines have always contained AAHS in them.

For decades these labels have been incorrect.

Dr. Humphries explains an important implication and one that nullifies the Cochrane Review into aluminium.

In 2004 a Cochrane review of aluminium was undertaken and published in The Lancet,

“We found no evidence that aluminium salts in vaccines cause any serious or long-lasting adverse events. Despite a lack of good-quality evidence we do not recommend that any further research on this topic is undertaken.”

But as Dr. Humphries points out, these reviews were performed on aluminium hydroxide or aluminium phosphate where in reality the vaccines contained amorphous aluminium hydroxyphosphate sulphate or AAHS.

“The fact is that by 2004 vaccine manufacturers knew full well that the labelling was false and never informed.”
– Dr. Thomas Jefferson

The repercussions of this as activist, Elizabeth Hart, suggests:

“Jefferson et al’s scientifically unsound review has facilitated poorly evidenced acceptance of the safety of aluminium-adjuvanted vaccines.  As a consequence, an increasing number of aluminium-adjuvanted vaccines are being added to vaccination schedules around the world… The long-term cumulative effects of the ever-growing list of vaccine products are unknown.”

The number of girls and boys experiencing adverse events following their Gardasil vaccination continues to grow at a faster and more alarmingly rate than that of other vaccines. To date, there are over 85,000 reports on the World Health Organisation’s database, VigiBase. The use of amorphous aluminium hydroxyphosphate sulphate or (AAHS) causes the immune system to become 104 times more powerfully stimulated than what would occur naturally. Such overstimulation of the immune system results in the development of more dangerous allergies, especially asthma. It also causes the manifestation of autoimmune diseases and seizures and all of the conditions that are occurring in our young teenagers after HPV vaccination including POTS or postural orthostatic tachycardic syndrome, gastrointestinal problems, heart disease, cancer, hair loss, depression, insomnia, and excruciating joint pain.

Aluminium is indeed, immunology’s dirty little secret.

See: Gardasil: Fast-Tracked and Flawed

high res

This article was originally published by Collective Evolution

 

 

 

Leave a comment

Filed under Aluminium, books, health, Uncategorized, vaccination, vaccines

Harare’s Herald lauds Zimbabwe’s HPV vaccination programme

Screen Shot 2018-05-05 at 5.19.01 PM

This week in Mutare, Zimbabwe, First Lady Auxilia Mnangagwa launched the National Human Papillomavirus (HPV) vaccination programme. The vaccine is to be given to over 800,000 girls between the ages of 10 to 14 in an attempt to alleviate the country’s growing cervical cancer rate. However in light of the fact that there is no proof that HPV vaccines have ever prevented a single case of the disease any decrease in the rate of the cancer from this provision alone will not take place.

The Herald refers to the benefit that this decision will bring to young girls and provides further details:

 Beneficiaries will be vaccinated against cervical cancer between now and May next year

From my vast research on the subject of Gardasil and other HPV vaccines the only beneficiaries are likely to be the vaccine industry. To date there have been over 85,000 recorded adverse events following the administration of Gardasil. This is far from the correct number of events for many of the injured and their doctors are uninformed of the existence of vaccine adverse event databases such as Vaers or VigiBase .

These life-altering events include sudden collapse with unconsciousness within 24 hours seizures; muscle pain and weakness; disabling fatigue; Guillain-Barr Syndrome (GBS); facial paralysis; brain inflammation; rheumatoid arthritis; lupus; blood clots; optic neuritis; multiple sclerosis; strokes; heart and other problems, including death.

Zimbabwe does not need this vaccine. There is an estimated 2, 270 women diagnosed with cervical cancer in Zimbabwe annually with a mortality rate of 64 percent so yes something needs to be done to address the level of cancer and the lack of appropriate treatment facilities. But there are other and much safer ways to fix the problem.

However when there are organisations such as the GAVI Alliance, a multibillion-dollar public–private partnership that funds and delivers vaccines to developing countries, and which in 2013 introduced HPV vaccines in eight African countries with it’s aim to vaccinate 30 million girls in 40 nations by 2020 then any other way of looking at the problem is ignored.

The GAVI Alliance, based on partnership between the public and private sectors, was launched in 1999 to combat falling immunisation levels by providing vaccines to 74 of the world’s poorest countries. Dubbed the “billion dollar fund” after a contribution of $750m (£517m; 839m) from Microsoft’s founder and chief executive, Bill Gates, it seeks to achieve this by incorporating new vaccines into national health systems while promoting the existing immunisation program

Criticism of GAVI is not hard to find with Princeton University academic Donald Light reporting in The Guardian that

“I think the taxpayers of affluent countries and their leaders should support saving poor children and reducing global poverty but this is a moment when they could critically review how that money is being spent.” …”The Gavi model depends on giving more and more money year after year to get vaccines to poor countries in ways that are not self-sustaining and at prices that are unaffordable.”

 

Before the advent of HPV vaccines it was found that social circumstances such as poverty and inequality were strongly implicated in the development of cervical cancer. It is well documented that tobacco smoking, having multiple children and the long-term use of hormonal contraceptives are associated with an increased risk of cervical cancer. When a woman stops taking hormonal contraceptives, the risk gradually declines.

Other factors that contribute to the cancer rate are the late presentation of disease, poor screening, and inadequate diagnosis and treatment facilities.

Knowing the risk factors and addressing them will help reduce the burden and mortality of cervical cancer along with the provision of Pap smear screening facilities and access to treatment for cervical lesions and cervical cancer.

Although there is government and public support for cervical cancer screening throughout the world, many countries lack well-funded, organised programs such as exist in the UK, Australia and other developed nations. From the 1960s to 1991, cervical cancer screening was available to women in Australia on an opportunistic basis in that the test was done on the request of the doctor or the woman herself. Then, in 1991, an organised program was set up which in 1995 became the National Cervical Screening Program. Such organised programs are more effective than those of an opportunistic nature because they specify a defined target population and include policies on method and interval of screening. Europe has few such organised programs with many countries relying on opportunistic screening. Screening in the USA and Canada varies from opportunistic to organised screening, and among the Latin American countries, Chile and Colombia boast national organised programs that have been operating for at least 15 years. Of all the countries in Africa, only South Africa has an official national cervical screening policy. Developing nations such as India have no organised screening program, with testing only available to a small population of mainly urban women. Since the Australian National Cervical Screening Program began in 1991, the number of deaths from the disease have halved.

The rollout makes Zimbabwe the eighth African country to introduce the HPV vaccine into its routine immunisation programme. The others are Botswana, Kenya, Mauritius, Rwanda, Seychelles, South Africa and Uganda. This is tragic!

See: Gardasil: Fast-Tracked and Flawed

 

high res

 

 

 

Leave a comment

Filed under books, gardasil, health, journalism, media representation, news, politics, vaccination, vaccines, womens rights